Deepak S. Nath, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 2,833 shares at $39.28 ($112K) on 2016-02-29, disclosed to the SEC on 2016-03-02.
Scheduled sale ($112k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.27 | 693 | $27K | 24.3% |
| 2 | $39.28 | 100 | $4K | 3.5% |
| 3 | $39.52 | 2,040 | $81K | 72.1% |
| Total | $39.45 avg | 2,833 | $112K | 100% |
| Filing → |
| ABT | SELL | 2016-04-29 | $2K | — | Filing → |
| ABT | SELL | 2016-02-23 | $12K | — | Filing → |
| ABT | SELL | 2016-02-17 | $6K | — | Filing → |